

Cover Story
Free
By Alexandria Carolan
A sense of foreboding descended on Narjust Duma as she sat at a presentation on drug-induced toxicities. The year was 2018, Duma was a 31-year-old second-year fellow at Mayo Clinic, and her discomfort stemmed from something other than the subject matter discussed.
In Brief


Clinical Roundup
Drugs & Targets
Trending Stories
- Charles Rudin named cancer center director at MSK
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure
- Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use
- NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing














